These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 25506447)
1. PML-IRIS during Fingolimod Diagnosed after Natalizumab Discontinuation. Killestein J; Vennegoor A; van Golde AE; Bourez RL; Wijlens ML; Wattjes MP Case Rep Neurol Med; 2014; 2014():307872. PubMed ID: 25506447 [TBL] [Abstract][Full Text] [Related]
2. Progressive Multifocal Leukoencephalopathy and Immune Reconstitution Inflammatory Syndrome after Discontinuation of Fingolimod. Piñar Morales R; Carrasco Garcia M; Gutierrez-Rojas L; Barrero Hernández FJ Case Rep Neurol; 2022; 14(1):38-43. PubMed ID: 35350291 [TBL] [Abstract][Full Text] [Related]
3. Progressive multifocal leukoencephalopathy or immune reconstitution inflammatory syndrome after fingolimod cessation? A case report. Mickeviciene D; Baltusiene A; Afanasjeva B; Afanasjevas D; Gleizniene R; Rastenyte D; Berger JR BMC Neurol; 2022 Aug; 22(1):306. PubMed ID: 35986243 [TBL] [Abstract][Full Text] [Related]
4. Immune-reconstitution Inflammatory Syndrome in Multiple Sclerosis Patients Treated With Natalizumab: A Series of 4 Cases. N'gbo N'gbo Ikazabo R; Mostosi C; Quivron B; Delberghe X; El Hafsi K; Lysandropoulos AP Clin Ther; 2016 Mar; 38(3):670-5. PubMed ID: 26856928 [TBL] [Abstract][Full Text] [Related]
5. Treatment of progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome with intravenous immunoglobulin in a patient with multiple sclerosis treated with fingolimod after discontinuation of natalizumab. Calic Z; Cappelen-Smith C; Hodgkinson SJ; McDougall A; Cuganesan R; Brew BJ J Clin Neurosci; 2015 Mar; 22(3):598-600. PubMed ID: 25523125 [TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging changes following natalizumab discontinuation in multiple sclerosis patients with progressive multifocal leukoencephalopathy. Hodel J; Bapst B; Outteryck O; Verclytte S; Deramecourt V; Benadjaoud MA; Pruvo JP; Vermersch P; Leclerc X Mult Scler; 2018 Dec; 24(14):1902-1908. PubMed ID: 29343163 [TBL] [Abstract][Full Text] [Related]
7. Natalizumab-Related Progressive Multifocal Leukoencephalopathy-Immune Reconstitution Inflammatory Syndrome: A Case Report Highlighting Clinical and MRI Features. Purohit B; Ganewatte E; Kollias SS Malays J Med Sci; 2016 Sep; 23(5):91-95. PubMed ID: 27904430 [TBL] [Abstract][Full Text] [Related]
8. Progressive Multifocal Leukoencephalopathy in a Multiple Sclerosis Patient Diagnosed after Switching from Natalizumab to Fingolimod. Sinnecker T; Othman J; Kühl M; Metz I; Niendorf T; Kunkel A; Paul F; Wuerfel J; Faiss J Case Rep Neurol Med; 2016; 2016():5876798. PubMed ID: 27994897 [No Abstract] [Full Text] [Related]
9. Extensive immune reconstitution inflammatory syndrome in Fingolimod-associated PML: a case report with 7 Tesla MRI data. Sinnecker T; Hadisurya J; Schneider-Hohendorf T; Schwab N; Wrede K; Gembruch O; Gold R; Hellwig K; Pilgram-Pastor S; Adams O; Albrecht P; Hartung HP; Aktas O; Kraemer M BMC Neurol; 2019 Aug; 19(1):190. PubMed ID: 31399069 [TBL] [Abstract][Full Text] [Related]
10. The chameleon of neuroinflammation: magnetic resonance imaging characteristics of natalizumab-associated progressive multifocal leukoencephalopathy. Wattjes MP; Richert ND; Killestein J; de Vos M; Sanchez E; Snaebjornsson P; Cadavid D; Barkhof F Mult Scler; 2013 Dec; 19(14):1826-40. PubMed ID: 24192217 [TBL] [Abstract][Full Text] [Related]
11. Surgical management of malignant cerebral edema secondary to immune reconstitution inflammatory syndrome from natalizumab-associated progressive multifocal encephalopathy. Tan LA; Lopes DK J Clin Neurosci; 2015 Oct; 22(10):1669-71. PubMed ID: 26115897 [TBL] [Abstract][Full Text] [Related]